This study was conducted to determine the fungi associated with persistent cough in immunocompromised patients attending Jos University Teaching Hospital (JUTH) and Vom Christian Hospital both in Plateau State. Hundred (100) immunocompromised patients with persistent cough were selected by random sampling. The sputum samples were collected and assayed for fungi using standard methods. The degree of disparity was analyzed using statistical method. Four different fungi were isolated from sputum of 37 (37%) immunocompromised patient with persistent cough, with Candida albicans been the highest 18 (48.6%) followed by Aspergillus niger 12 (32.4%), Cryptococcus neoformans 5 (13.5%) and Penicilium species 2(5.4%). Male subjects 22 (22%) were more susceptible to fungi associated cough than female 15(15%) with significant difference (P value 0.026). HIV, Tuberculosis and co-infection of both (HIV and TB) and prolong use of antibiotics were more predisposing factor associated with fungi related cough. These isolates were tested on 5 antifungal drugs. Ketoconazole and intraconazole were most susceptible to 83.8% of isolates, Amphotericin B had 54.1% susceptible while Griseofulvin and Vericonazole were 18.9% susceptible to the isolates. However, in managing the immunocompromised patient, there is a need for antifungal prophylaxis and sending of sample of immunocompromised host with persistent cough not only for bacteriological analysis but also mycological evaluation.
D. K Leventin and O. Burge, “What are Fungi?” Fungal infection Treatment information. 32 (2): 5-7, (2007).
R. I. Adams, M. Miletto, J. W. Taylor and T. D. Bruns, “Dispersal in microbes: fungi in indoor air are dominated by outdoor air and show dispersal limitation at short distances”, J. International Society for Microbial Ecology, 1–12, (2013).
K. Thakur, G. Singh, S. Agarwal, L. Rani, “Meningitis caused by Rhodotorula rubra in an human immunodeficiency virus infected patient” Indian Journal of Medical Microbiology, 25(2): 166-168, (2007).
M. A. Pfaller, and D. J. Diekema. “Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus”. Journal of Clinical Microbiology vol. 42 no. 10 4419-4431, (2004)
T. H. Merritt and J. Segreti “The role of the infectious disease specialist in the diagnosis and treatment of primary immunodeficiency disease”. Infect Dis Clin Pract.;19(5):316-325, (2011)
L. M. Prescolt, J. P. Harley, and D. A. Klein “Human Disease caused by fungi and protozoa in review of Microbiology”. 5th ed Mc Graw-Hill companies Inc publish. New York. Pp 941-978. (2002).
S. U. Omar, G. B. Maria, J. P. Hema, C. Natascia, A. B. Mark, K. Marta, K. Dezso, and J. B. Peter, “Theobromine inhibit sensory nerve activation and cough”. The FASEB J. 19: 231-233, (2005).
L. Sung “Invasive fungal infections in children with cancer”. J Pediatr.;156 (2):68-73. (2010).
R. Jain, D. Agarwal, T. K. Lahiri, V. Tilak and A. Gulati, “Successful treatment of invasive pulmonary aspergillosis in an Immunocompetent host” Respirology 10(3): 393-5, (2007).
N. T. Dabo and M. Yusha’u, “Incidence of Systemic Mycoses. In Patients With Suspected Tuberculosis in Kano, Nigeria”. International Journal of Pure and Applied Science, 1(1): 35-39, (2010).
J. Ochei and A. Kolhatkar, “Laboratory Techniques in mycology”. In: Bulakh P.M. and Deshmukh, S.eds. Medical Laboratory Science Theory and Practise. 3rd edn. Tata McGraw-Hill publication. New Delhi. Pp 1056-1105, (2005).
M. D. Mukhtar and M. Huda, “Prevalence of Tinea capitis in primary school and sensitivity of etiological agent to Pistia stratiotes extracts; Detection and isolation of C. albicans.” Nig. J. Microbiol. 19(1-2): 412-419, (2005).
R. S. Iyer, R. B. Pal, R. Y. Patel and D. D. Banker, “Polymerase Chain Reaction based diagnosis of systemic fungal infections and sensitivity testing of the fungal isolates”. Indian J. Med. Microl. 20(3): 132-136, (2002).
J. M. Wiley, “Fungal infections in pediatric immunocompromised patients: epidemiology, principles of treatment, an promising antifungal agents”. J Pediatr. 156 (2):74-82, (2010).
B. Fernandez-Torres, A. J. Carrillo, E. Martin, A. Del Palacio, M.K Moore, A. Valverde, M. Serrano, and J. Guarro, “In vitro Activities of 10 Antifungal against 508 Dermatophyte Strains”. J. Antimicrob. Agents Chemother. 45 (9): 2524-2528, (2001).
H. L. Hoffman and M. A. Pfaller, “In vitro Antifungal Susceptibility Testing”. J Pharmacotherapy 21 (8s): 111-123, (2001).
J. Lambourne, D. Agranoff, R. Herbrecht, P. F Troke, A. Buchbinder, F. Willis. “Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients”. Clin Infect Dis.15; 49(10):1486-91, (2009).
Clinical and Laboratory Standards institute (CLSI). “Methods for the dilution, antimicrobial susceptibility test for bacteria. Approved standards. Ninth Editions(M09)”, (2010).
L. A. Shailaja, L. A. Pai, D.R. Mathur and V. Lakshmi, “Prevalence of bacterial and fungal agents causing lower respiratory tract infections in patient with cough”. J of Microbiology 22: 28-33, (2004).
M. N. Chowta, P. Adhikari, A. Rajeev, A. K. Shenoy, “Study of the risk factors and prevalence of invasive candidiasis in a tertiary care hospital”. Indian J. Crit. Med. 11: 67-73, (2007).
E. Jawetz, J. L. Melnick, E. A. Adelberg, “Medical mycology”. In: G. F. Brooks, J. S. Butel, S. A. Morse. eds. Review of Medical Microbiology. 23rd edn. Lange Medical Publication. Los Angeles California. pp 531-555.
This work is licensed under a Creative Commons Attribution 4.0 International License.